FINE yields 0.98% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, FINE + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FINE + MRK for your $10,000?
FINE aims to replicate an index of European companies generating at least 50% of their revenues from luxury-related business operations. The index is focused on companies headquartered in developed Europe, such as Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, or the United Kingdom. Eligible securities must meet certain size and trading volume requirements. After this basic screen, a proprietary natural language processing algo screens publicly available information such as financial news and business profiles to identify and score companies involved in the investment theme. These may include firms involved in the design, manufacturing, or sale of luxury and designer accessories, high-end or designer clothing and beauty products, exclusive and luxurious automobiles and boats, luxury hotels, resorts, and spas. The 25 highest ranking companies are included in the index and are given an equal weighting. The index is reconstituted annually and rebalanced semi-annually.
Full FINE Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.